Cargando...
Modulatory effects of bortezomib on host immune cell functions
Bortezomib is an inhibitor of the ubiquitin-proteasome proteolytic pathway responsible for intracellular protein turnover. Cellular proteins controlled by this pathway represent a diverse group of potential therapeutic targets, particularly in cancer cells, which exploit this proteasomal pathway to...
Guardado en:
| Publicado en: | Immunotherapy |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648628/ https://ncbi.nlm.nih.gov/pubmed/26325610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.15.66 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|